Navigation Links
Gulf Breeze Recovery on Methamphetamine Deaths - Autopsies Reveal the Truth

Autopsies don’t lie. They report the causes of death as well as what has caused damage or injury to the body.

Methamphetamine permanently harms the heart. It increases risks of heart attack and death. Autopsies definitively prove it. Through autopsies, doctors are getting a better understanding of how the damage occurs.

An August 1, 2019 article in U.S. News and World Report discussed findings researchers from Louisiana State University presented to the American Heart Association."We found methamphetamine has profound harmful effects on the cardiovascular system and results in irreversible damage to the heart, raising the risk of a heart attack, sudden cardiac arrest, and heart failure," postdoctoral fellow at LSU's Health Sciences Center in Shreveport and study co-lead author Chowdhury Abdullah said in the heart association news release.

In comparison to samples from non-users, samples from the heart’s main pumping chamber (left ventricle) in meth users showed:

  • Increased deposits of collagen (stiff protein fibers) around the blood vessels.
  • Accumulation of collagen throughout the spaces between heart muscle cells.

Methamphetamine, commonly known as meth, is a stimulant that is absorbed in the digestive tract and is metabolized primarily in the liver. It speeds up systems in the body. Methamphetamine is sometimes legally prescribed as Desoxyn®(Methamphetamine Hydrochloride tablets) to treat attention deficit hyperactivity disorder or obesity.

Even when taken with medical supervision and used as prescribed, Desoxyn comes with warnings from the manufacturer of the possibility for serious cardiovascular events. The manufacturer of the medication warning states that sudden death has been reported in association with CNS (central nervous system) stimulant treatment at usual doses in children and adolescents with structural cardiac abnormalities or other serious heart problems, and that sudden deaths, stroke, and myocardial infarction have been reported in adults taking stimulant drugs at usual doses for ADHD.

The Food and Drug Administration requires a black box warning on a prescription drug’s label that is designed to call attention to serious or life-threatening risks. The prescription black box warning for Desoxyn states:

Methamphetamine has a high potential for abuse. Particular attention should be paid to the possibility of subjects obtaining methamphetamine for non-therapeutic use or distribution to others, and the drug should be prescribed or dispensed sparingly. Misuse of methamphetamine may cause sudden death and serious cardiovascular adverse events

Those risks naturally multiply for individuals who are using methamphetamine recreationally that is produced and sold illegally with no controls for purity or dosage.

According to the 2017 National Survey on Drug Use and Health (NSDUH), approximately 1.6 million people (0.6 percent of the population) reported using methamphetamine in the past year, and 774,000 (0.3 percent) reported using it in the past month. The average age of new methamphetamine users in 2016 was 23.3 years old.

In 2017, Newsroom reported that illegal methamphetamine use was on the rise with U.S. veterans, as was heart failure associated with methamphetamine use. A study was completed of 9,588 veterans who were patients at the San Diego VA Medical center and were diagnosed with heart failure between 2005 and 2015. They found that meth use increased from 1.7 percent among VA heart failure patients in 2005 to 8 percent in 2015.

Other pertinent findings on the veterans who reported using methamphetamine were:

  • Meth users with heart failure, with an average age of 61, were notably younger than non-meth user heart failure patients, whose average age was 72 years.
  • Meth users were more likely to have psychiatric issues, such as depression and post-traumatic stress disorder, or PTSD.
  • Meth patients tended to visit the emergency department more often compared to heart failure patients without meth use.

Autopsies confirm, Methamphetamine is deadly.

About Gulf Breeze Recovery: Gulf Breeze Recovery, one of the holistic treatment centers in Florida, is changing the future of addiction treatment with the THRIVE® program focused on overcoming chronic relapse. Gulf Breeze Recovery’s THRIVE® program is a non-12-step approach and individualized designed for those who are looking for a drug and alcohol treatment program to produce a different and positive result. This non-12 step program allows you to drive beyond your addictions and promotes a new outlook on life. For more information about our program or to speak with an Addiction’s expert, please call 855-973-3551 or contact us.

Read the full story at

Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved

Related medicine news :

1. Gulf Breeze Recovery Comments on New Opioid Antidote Alternative to Narcan
2. Gulf Breeze Recovery on Reduction in Opioid Deaths and an Increase in Hope
3. Gulf Breeze Recovery Applauds Google's Decision on Deceptive Drug Rehab Advertising
4. Power Breezer Debuts New Ductwork Extension at the National Safety Council Congress and Expo
5. Urbini Breezes Through Summer with New Jogging Stroller
6. $1 Million Awarded for Prevention, Treatment and Recovery Efforts to ‘Fight’ Opioid Addiction in Stephens County Through “HOPE” Initiative
7. New Eating Disorder Recovery Program to Open in Huntsville
8. More Labs, makers of successful liver detox drink Morning Recovery, announces the addition of hydration powder, Aqua+, to its line of supplement offerings
9. BayMark Health Services Opens AppleGate Recovery In Blacksburg, Va
10. AppleGate Recovery Opens Physician Based Opioid Treatment Center In Richmond, VA
11. Rancho Milagro Recovery Receives Joint Commission (JCAHO) Accreditation
Post Your Comments:
(Date:11/7/2019)... ... , ... Atlantic Ultraviolet Corporation makes it their business to fight the flu. ... the flu season starts in October until March, Atlantic Ultraviolet makes it a point ... sign-up and get their shot. , Ann Wysocki, COO of Atlantic Ultraviolet Corporation® says, ...
(Date:11/7/2019)... ... 2019 , ... Understanding UDI in EU Device Regulations, An FDAnews Webinar, Thursday, ... EU device and IV diagnostics sales in jeopardy? , It’s not a trick question. ... and many device and diagnostics makers simply aren’t prepared. , Not yet anyway. , ...
(Date:11/6/2019)... ... November 06, 2019 , ... SPH Analytics ... announced today that 94% of the health insurance plans receiving the highest 4.5- ... insurance plans, use SPH solutions according to reports recently released by ...
(Date:11/6/2019)... ... November 06, 2019 , ... Conducting Advanced Root Cause Analysis ... An FDAnews Workshop, Nov. 13-14, 2019 • Philadelphia, PA, ... Dear FDA-Regulated Executive, , CAPA failures show up in about half of all ...
(Date:11/5/2019)... SEATTLE (PRWEB) , ... November 05, 2019 , ... ... informed care strategies, announces Associate Managing Editor, Sabitha Rajan, MD, MSc, will be a ... Conference + Expo on Nov. 12, 2019, at 9:00 a.m., in Austin, Texas. ...
Breaking Medicine News(10 mins):
(Date:11/11/2019)... ... November 11, 2019 , ... ... and have a major impact in the oncology field. While these approaches ... be overcome. Among these, defining valuable and adapted combination protocols, predicting responders ...
(Date:11/11/2019)... ... 10, 2019 , ... Carex, a subsidiary of Compass Health ... which features over 600 available products and improved navigation with a stronger user ... health and wellness products, alongside, studies showing that over 90% of people ...
(Date:11/11/2019)... ... November 11, 2019 , ... ... Practice Management and Patient Engagement solutions, welcomed ConnectiveRX as a Silver Sponsor, and ... (NUCON) 2019, held in Cincinnati, on October 18 - 19. The annual conference ...
Breaking Medicine Technology: